Literature DB >> 22878465

Microparticles: Modulators and biomarkers of liver disease.

Miroslaw Kornek1, Detlef Schuppan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22878465     DOI： 10.1016/j.jhep.2012.07.029

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  12 in total

Review 1.  Strategies and endpoints of antifibrotic drug trials: Summary and recommendations from the AASLD Emerging Trends Conference, Chicago, June 2014.

Authors:  Natalie J Torok; Jonathan A Dranoff; Detlef Schuppan; Scott L Friedman
Journal:  Hepatology       Date:  2015-03-10       Impact factor: 17.425

2.  Role of procoagulant microparticles in mediating complications and outcome of acute liver injury/acute liver failure.

Authors:  R Todd Stravitz; Regina Bowling; Robert L Bradford; Nigel S Key; Sam Glover; Leroy R Thacker; Don A Gabriel
Journal:  Hepatology       Date:  2013-05-14       Impact factor: 17.425

3.  Processing of miR17-92 Cluster in Hepatic Stellate Cells Promotes Hepatic Fibrogenesis During Alcohol-Induced Injury.

Authors:  Elizabeth Brandon-Warner; Nicole A Feilen; Catherine R Culberson; Conroy O Field; Andrew S deLemos; Mark W Russo; Laura W Schrum
Journal:  Alcohol Clin Exp Res       Date:  2016-06-13       Impact factor: 3.455

Review 4.  Evolving therapies for liver fibrosis.

Authors:  Detlef Schuppan; Yong Ook Kim
Journal:  J Clin Invest       Date:  2013-05-01       Impact factor: 14.808

Review 5.  Extracellular Vesicles: A New Frontier in Biomarker Discovery for Non-Alcoholic Fatty Liver Disease.

Authors:  Linda A Ban; Nicholas A Shackel; Susan V McLennan
Journal:  Int J Mol Sci       Date:  2016-03-14       Impact factor: 5.923

Review 6.  Large Extracellular Vesicles: Have We Found the Holy Grail of Inflammation?

Authors:  Artur Słomka; Sabine Katharina Urban; Veronika Lukacs-Kornek; Ewa Żekanowska; Miroslaw Kornek
Journal:  Front Immunol       Date:  2018-12-13       Impact factor: 7.561

7.  Extracellular Vesicles in Liver Diseases: Meeting Report from the International Liver Congress 2018.

Authors:  Jesus M Banales; Ariel E Feldstein; Hanna Sänger; Veronika Lukacs-Kornek; Gyongyi Szabo; Miroslaw Kornek
Journal:  Hepatol Commun       Date:  2019-01-02

Review 8.  Extracellular vesicle profiling and their use as potential disease specific biomarker.

Authors:  Henrike Julich; Arnulf Willms; Veronika Lukacs-Kornek; Miroslaw Kornek
Journal:  Front Immunol       Date:  2014-09-01       Impact factor: 7.561

9.  Low levels of IgM antibodies recognizing oxidation-specific epitopes are associated with human non-alcoholic fatty liver disease.

Authors:  Tim Hendrikx; Martin L Watzenböck; Sofie M A Walenbergh; Shahzada Amir; Sabrina Gruber; Maria Ozsvar Kozma; Heike I Grabsch; Ger H Koek; Marieke J Pierik; Katharina Staufer; Michael Trauner; Satish C Kalhan; Daisy Jonkers; Marten H Hofker; Christoph J Binder; Ronit Shiri-Sverdlov
Journal:  BMC Med       Date:  2016-07-22       Impact factor: 8.775

10.  Tumour-associated circulating microparticles: A novel liquid biopsy tool for screening and therapy monitoring of colorectal carcinoma and other epithelial neoplasia.

Authors:  Arnulf Willms; Clara Müller; Henrike Julich; Niklas Klein; Robert Schwab; Christoph Güsgen; Ines Richardsen; Sebastian Schaaf; Marcin Krawczyk; Marek Krawczyk; Frank Lammert; Detlef Schuppan; Veronika Lukacs-Kornek; Miroslaw Kornek
Journal:  Oncotarget       Date:  2016-05-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.